Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Short-term Investments: 2010-2025

Historic Short-term Investments for BIO-TECHNE (TECH) over the last 15 years, with Jun 2025 value amounting to $2.8 million.

  • BIO-TECHNE's Short-term Investments fell 71.03% to $2.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.8 million, marking a year-over-year decrease of 71.03%. This contributed to the annual value of $2.8 million for FY2025, which is 71.03% down from last year.
  • Per BIO-TECHNE's latest filing, its Short-term Investments stood at $2.8 million for Q2 2025, which was down 11.90% from $3.2 million recorded in Q4 2024.
  • In the past 5 years, BIO-TECHNE's Short-term Investments ranged from a high of $90.1 million in Q1 2021 and a low of $2.8 million during Q2 2025.
  • Moreover, its 3-year median value for Short-term Investments was $11.6 million (2023), whereas its average is $13.0 million.
  • Per our database at Business Quant, BIO-TECHNE's Short-term Investments slumped by 73.88% in 2021 and then surged by 129.37% in 2022.
  • BIO-TECHNE's Short-term Investments (Quarterly) stood at $67.1 million in 2021, then crashed by 52.22% to $32.1 million in 2022, then plummeted by 63.87% to $11.6 million in 2023, then plummeted by 72.15% to $3.2 million in 2024, then slumped by 71.03% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q2 2025, $3.2 million for Q4 2024, and $6.7 million during Q3 2024.